Safety and efficacy of a milk-derived extract in the treatment of plaque psoriasis: An open-label study

Journal of Cutaneous Medicine and Surgery

Volumn 9, Issue 6, 2005, Pages 271-275

  Poulin, Y ^a   Pouliot, Y ^b   Lamiot, E ^b   Aattouri, N ^b   Gauthier, S F ^c  

^a Centre de Recherche Dermatologique du Québec Métropolitain CRDQ   (Canada)

^b Advitech Inc   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; CORTICOSTEROID; CREATININE; SALICYLIC ACID; UNCLASSIFIED DRUG; XP 828L;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MILK; OPEN STUDY; PRIORITY JOURNAL; PSORIASIS VULGARIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS; INFORMED CONSENT; LACTALBUMIN; LACTOFERRIN; MALE; MIDDLE AGED; MILK PROTEINS; PSORIASIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33749326727     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-005-0103-6     Document Type: Article

References (17)

1. Stern RS. Psoriasis. Lancet 1997; 350:349-353.
2. Lebwohl M. Psoriasis. Lancet 2003; 361:1197-1204.
3. Prinz JC. The role of T cells in psoriasis. J Eur Acad Dermatol Venereol 2003; 17:257-270.
4. Naldi L, Svensson A, Diepgen T, et al. Randomized clinical trials for psoriasis. 1977-2000: the EDEN survey. J Invest Dermatol 2003; 120:738-741.
5. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003; 49:S44-S50.
6. Soyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med 1993; 238:1812-1816.
7. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21:495-505.
8. Mayser P, Grimm H, Grimminger F. n-3 fatty acids in psoriasis. Br J Nutr 2002; 87(Suppl 1):S77-S82.
9. Playford RJ, Macdonald CE, Johnson WS. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 2000; 72:5-14.
10. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defence. Biochem Cell Biol 2002; 80:95-102.
11. Otani H, Hata I. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. J Dairy Res 1995; 62:339-348.
12. Gill HS, Doull F, Rutherfurd KJ, et al. Immunoregulatory peptides in bovine milk. The British Journal of Nutrition 2000; 84:S111-S117.
13. Korhonen H, Marnila P, Gill HS. Bovine milk antibodies for health. Br J Nutr 2000; 84(Suppl 1):S135-S146.
14. Aattouri N, Gauthier SF, Santure M, et al. Immunosuppressive effect of a milk-derived extract. Immunology 2004; 1-4.
15. Langley RG, Ellis N. Evaluating psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. J Acad Dermatol 2004; 51(4):563-569.
16. Gottlieb AB, Kang S, Linden KG, et al. Evaluation of safety and clinical activity of multiple doses of the anti-CD80, galiximab, in patients with moderate to severe psoriasis. Clinical Immunology 2004; 111:28-37.
17. Sharma K, McGowan TA. TGF-β in diabetic kidney disease: role of novel signaling pathway. Cytokine Growth Factor Rev 2000; 11:115-123.